Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.

Abstract:

:In the diagnosis of non-Hodgkin's lymphomas, the ready characterization of the neoplastic cell lineage by analysis of cell surface markers is of great importance. We present evidence for the existence of a human B-leukemia-associated antigen recognized by a complement-fixing monoclonal antibody (anti-Y 29/55). A hybridoma was produced by fusing mouse myeloma cells and splenocytes of a mouse immunized against lymphoid cells of a patient with B-cell chronic lymphocytic leukemia. Characterization of anti-Y 29/55-reactive normal and malignant leukocytes was demonstrated by cytolysis and indirect immunofluorescence. This revealed reactivity with an antigen on B-lymphoma cells (11 patients), on leukemic lymphocytes in B-cell chronic lymphocytic leukemia (13 patients), and on malignant cells in hairy-cell leukemia (two patients) but not on leukemic cells of T-cell acute lymphoblastic leukemia (one patient), on T-lymphoma cells (one patient), on cells of acute myeloblastic leukemia (four patients), or of chronic myeloid leukemia (four patients). No specific cytolysis occurred with B- and T-peripheral blood lymphocytes from (a) healthy donors (16 individuals), (b) patient with reactive lymphocytosis (one patient), (c) nonleukemic multiple myeloma (six patients), or (d) Hodgkin's disease (three patients). Surface immunoglobulin-positive, sheep RBC-negative lymphocytes isolated from human spleen (three individuals), tonsils (seven individuals), and lymph nodes (one individual), however, were recognized. It is concluded that leukemic B-cells carry a marker characteristic of nonrecirculating sessile B-lymphocytes.

journal_name

Cancer Res

journal_title

Cancer research

authors

Forster HK,Gudat FG,Girard MF,Albrecht R,Schmidt J,Ludwig C,Obrecht JP

subject

Has Abstract

pub_date

1982-05-01 00:00:00

pages

1927-34

issue

5

eissn

0008-5472

issn

1538-7445

journal_volume

42

pub_type

杂志文章
  • Treatment of glioma by engineered interleukin 4-secreting cells.

    abstract::The ability of interleukin-4 (IL-4) to mediate an antitumor response to human gliomas was studied in vivo in nude mice. To allow the effect of IL-4 to be exerted over a relatively short distance and at an optimal concentration, a transfected tumor cell line expressing a high level of IL-4 was used in mixed tumor trans...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yu JS,Wei MX,Chiocca EA,Martuza RL,Tepper RI

    更新日期:1993-07-01 00:00:00

  • The 104-123 amino acid sequence of the beta-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion.

    abstract::The von Hippel-Lindau (VHL) tumor suppressor gene is mutated in patients with VHL disease and in the majority of patients with sporadic renal cell carcinomas (RCCs). RCCs are dependent on insulin-like growth factor-1 receptor-mediated signaling for tumor growth and invasion in vivo. Reintroduction of the VHL gene prod...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Datta K,Sundberg C,Karumanchi SA,Mukhopadhyay D

    更新日期:2001-03-01 00:00:00

  • Intracellular ATP levels determine cell death fate by apoptosis or necrosis.

    abstract::Although apoptosis and necrosis are morphologically distinct manifestations of cell death, apoptosis and some necroses share common features in the death signaling pathway involving functional steps of death-driving interleukin 1beta-converting enzyme family proteases and anti-cell death protein Bcl-2. One evident phy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eguchi Y,Shimizu S,Tsujimoto Y

    更新日期:1997-05-15 00:00:00

  • A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.

    abstract::Membrane-bound complement inhibitors protect host cells from inadvertent complement attack, and complement inhibitors are often up-regulated on tumors, possibly representing a selective adaptation by tumors to escape elimination by a host antitumor immune response. Relevant in vivo studies using rodent models of human...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Caragine TA,Okada N,Frey AB,Tomlinson S

    更新日期:2002-02-15 00:00:00

  • Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.

    abstract::Notch signaling is an area of great interest in oncology. RO4929097 is a potent and selective inhibitor of gamma-secretase, producing inhibitory activity of Notch signaling in tumor cells. The RO4929097 IC50 in cell-free and cellular assays is in the low nanomolar range with >100-fold selectivity with respect to 75 ot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1843

    authors: Luistro L,He W,Smith M,Packman K,Vilenchik M,Carvajal D,Roberts J,Cai J,Berkofsky-Fessler W,Hilton H,Linn M,Flohr A,Jakob-Røtne R,Jacobsen H,Glenn K,Heimbrook D,Boylan JF

    更新日期:2009-10-01 00:00:00

  • Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.

    abstract::Ovarian cancer is resistant to the antiproliferative effects of transforming growth factor-beta (TGF-beta); however, the mechanism of this resistance remains unclear. We used oligonucleotide arrays to profile 37 undissected, 68 microdissected advanced-stage, and 14 microdissected early-stage papillary serous cancers t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0683

    authors: Sunde JS,Donninger H,Wu K,Johnson ME,Pestell RG,Rose GS,Mok SC,Brady J,Bonome T,Birrer MJ

    更新日期:2006-09-01 00:00:00

  • Regulation of N-myc transcript stability in human neuroblastoma and retinoblastoma cells.

    abstract::Several studies have shown that neuroblastoma and retinoblastoma tumor cells often have elevated N-myc mRNA levels compared to normal adult neuronal or retinal tissues, and it has been suggested that increased expression of this protooncogene may play an important role in tumorigenesis or malignant progression in cell...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Amy CM,Bartholomew JC

    更新日期:1987-12-01 00:00:00

  • Akt SUMOylation regulates cell proliferation and tumorigenesis.

    abstract::Proto-oncogene Akt plays essential roles in cell proliferation and tumorigenesis. Full activation of Akt is regulated by phosphorylation, ubiquitination, and acetylation. Here we report that SUMOylation of Akt is a novel mechanism for its activation. Systematically analyzing the role of lysine residues in Akt activati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0538

    authors: Li R,Wei J,Jiang C,Liu D,Deng L,Zhang K,Wang P

    更新日期:2013-09-15 00:00:00

  • Responses of amphibian embryos and blastomeres to a tumor-promoting phorbol ester.

    abstract::Phorbol ester tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA) alter the morphology and differentiated states of numerous cell types in vitro. It is likely that these molecules are teratogenic for vertebrate embryos in which cytodifferentiation, cell-tissue interactions, and cellular motility are pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ellinger MS

    更新日期:1982-07-01 00:00:00

  • Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro.

    abstract::These studies explore the effects of an epipodophyllotoxin on the membrane transport and metabolism of thymidine in Ehrlich ascites tumor cells. Uptake of 3H after exposure of cells to [3H]-thymidine is characterized by a rapid initial velocity that approximates membrane transport followed by a slower rate of uptake t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yalowich JC,Goldman ID

    更新日期:1984-03-01 00:00:00

  • Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.

    abstract::In order to improve local control of tumors over that achievable with local hyperthermia and radiation, we are testing the use of systemic cis-diamminedichloroplatinum(II) (CDDP) in conjunction with the other two modalities. In the FSaIIC fibrosarcoma, growth delay experiments indicated that the use of any two modalit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Herman TS,Teicher BA

    更新日期:1988-05-15 00:00:00

  • Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.

    abstract::The chemosensitivity of human tumor xenografts to mitozolomide, 8-carbamoyl-3-(2-chloroethyl)imidazo[5-1-d]-1,2,3,5-tetrazin-4(3H) -one, was studied in 3 different assay systems. In concentrations of 1 to 500 micrograms/ml, mitozolomide completely inhibited the colony-forming ability in soft agar of cell suspensions f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fodstad O,Aamdal S,Pihl A,Boyd MR

    更新日期:1985-04-01 00:00:00

  • Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.

    abstract::PTEN/MMAC1 is a major new tumor suppressor gene that encodes a dual-specificity phosphatase with sequence similarity to the cytoskeletal protein tensin. Recently, we reported that PTEN dephosphorylates focal adhesion kinase (FAK) and inhibits cell migration, spreading, and focal adhesion formation. Here, the effects o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tamura M,Gu J,Takino T,Yamada KM

    更新日期:1999-01-15 00:00:00

  • Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.

    abstract::Triple-negative breast cancer (TNBC) is an aggressive clinical subtype accounting for up to 20% of all breast cancers, but its malignant determinants remain largely undefined. Here, we show that in TNBC the overexpression of Fra-1, a component of the transcription factor AP-1, offers prognostic potential. Fra-1 deplet...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3396

    authors: Zhao C,Qiao Y,Jonsson P,Wang J,Xu L,Rouhi P,Sinha I,Cao Y,Williams C,Dahlman-Wright K

    更新日期:2014-07-15 00:00:00

  • Aberrant mitochondria in two human colon carcinoma cell lines.

    abstract::Electron micrographs of CCL237 and FET cells (two slowly growing, differentiated human colon carcinoma lines) revealed enlarged mitochondria with few cristae. Polarographic measurement of respiratory activity in mitochondria isolated from these cell lines was compared to that of CV-1 cells (a normal monkey kidney epit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Modica-Napolitano JS,Steele GD Jr,Chen LB

    更新日期:1989-06-15 00:00:00

  • Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines.

    abstract::Metallothioneins (MT) are major cysteine-rich proteins with poorly characterized functions. We have examined the MT amount, isotype expression, and subcellular distribution in 4 human hormone-independent prostatic carcinoma cell lines. Both PC-3 and DU-145 cells were thiol-rich cells with similar MT and glutathione le...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kondo Y,Kuo SM,Watkins SC,Lazo JS

    更新日期:1995-02-01 00:00:00

  • A randomized trial of dietary intervention for breast cancer prevention.

    abstract::Epidemiologic data and animal experiments suggest that dietary fat may influence risk of breast cancer. To determine whether intervention with a low-fat, high-carbohydrate diet would reduce breast cancer incidence in women at increased risk of the disease, we carried out a randomized controlled trial in Canada. We rec...

    journal_title:Cancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.1158/0008-5472.CAN-10-1436

    authors: Martin LJ,Li Q,Melnichouk O,Greenberg C,Minkin S,Hislop G,Boyd NF

    更新日期:2011-01-01 00:00:00

  • CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.

    abstract::The chemokine receptor, CXCR4, is expressed by human melanomas, and its ligand, CXCL12, is frequently produced at sites of melanoma metastasis. Herein, we examine CXCR4-enhanced binding of B16 murine melanoma cells to endothelial cells (ECs) and recombinant adhesion molecules in vitro to determine the role of tumor- a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cardones AR,Murakami T,Hwang ST

    更新日期:2003-10-15 00:00:00

  • Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.

    abstract::Monoclonal antibodies (mAb) are widely used in the treatment of non-Hodgkin's lymphoma and autoimmune diseases. Although the mechanism of action in vivo is not always known, the therapeutic activity of several approved mAbs depends on the binding of the Fcgamma regions to low-affinity Fcgamma receptors (FcgammaR) expr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0696

    authors: Stavenhagen JB,Gorlatov S,Tuaillon N,Rankin CT,Li H,Burke S,Huang L,Vijh S,Johnson S,Bonvini E,Koenig S

    更新日期:2007-09-15 00:00:00

  • Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice.

    abstract::When human tumor xenotransplants into nude mice are used as experimental models, it is important to know whether their microvascular anatomy is rather host or tumor specific. Therefore a morphometric comparison of the vascular network in human squamous cell carcinomas and their xenotransplants was carried out. Biopsie...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lauk S,Zietman A,Skates S,Fabian R,Suit HD

    更新日期:1989-08-15 00:00:00

  • Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

    abstract::Alkyl-lysophospholipids have been shown to possess antitumoral activity in animal and in human tumors. Among them, racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine (ET-18-OCH3) had an antimetastatic effect in experimental tumors. We investigated the effect of ET-18-OCH3 on invasion of MO4 mouse fibrosarcoma ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Storme GA,Berdel WE,van Blitterswijk WJ,Bruyneel EA,De Bruyne GK,Mareel MM

    更新日期:1985-01-01 00:00:00

  • Fluidity of membrane lipids and lateral mobility of concanavalin A receptors in the cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias.

    abstract::Lymphocytes isolated from the peripheral blood of patients with nonmalignant and malignant disorders were studied for fluidity of membrane lipids and lateral mobility of concanavalin A (Con A) receptors. The degree of fluidity of the surface membrane lipid core was monitored quantitatively by fluorescence polarization...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ben-Bassat H,Polliak A,Rosenbaum SM,Naparstek E,Shouval D,Inbar M

    更新日期:1977-05-01 00:00:00

  • High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.

    abstract::Standardized and reproducible preclinical models that recapitulate the dynamics of prostate cancer are urgently needed. We established a bank of transplantable patient-derived prostate cancer xenografts that capture the biologic and molecular heterogeneity currently confounding prognostication and therapy development....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-2921-T

    authors: Lin D,Wyatt AW,Xue H,Wang Y,Dong X,Haegert A,Wu R,Brahmbhatt S,Mo F,Jong L,Bell RH,Anderson S,Hurtado-Coll A,Fazli L,Sharma M,Beltran H,Rubin M,Cox M,Gout PW,Morris J,Goldenberg L,Volik SV,Gleave ME,Collins

    更新日期:2014-02-15 00:00:00

  • G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones.

    abstract::Membranes from a B16 murine melanoma clone of high experimental metastatic capacity show increased amounts of pertussis toxin (PT) substrate when compared to a low metastatic counterpart. Using specific antibodies, we identified Gi2 as the PT-sensitive G-protein uniquely abundant in highly metastatic cells. ADP ribosy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lester BR,McCarthy JB,Sun ZQ,Smith RS,Furcht LT,Spiegel AM

    更新日期:1989-11-01 00:00:00

  • MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.

    abstract::Expression of the pro-oncogenic mucin MUC1 is elevated by inflammation in airway epithelial cells, but the contributions of MUC1 to the development of lung cancer are uncertain. In this study, we developed our finding that cigarette smoke increases Muc1 expression in mouse lung macrophages, where we hypothesized MUC1 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1713

    authors: Xu X,Padilla MT,Li B,Wells A,Kato K,Tellez C,Belinsky SA,Kim KC,Lin Y

    更新日期:2014-01-15 00:00:00

  • Effect of bleomycin on the synthesis and function of RNA.

    abstract::Bleomycin inhibits cellular RNA synthesis and the inhibition is nonspecific. The ratio of polyadenylate- [poly(A)] containing RNA to non-poly(A)-containing RNA in the drug-treated human lymphocytic cells, line Wil2, was the same as that in untreated cells. Poly(A) RNA isolated from untreated cells was used as a templa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kuo MT,Auger LT,Saunders GF,Haidle CW

    更新日期:1977-05-01 00:00:00

  • Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1 alpha) from Eb cells.

    abstract::Glycolipids of murine lymphoma cell lines with low metastatic (Eb) and high metastatic (ESb) potentials have been investigated. The Eb cell line was characterized by a high quantity of gangliotriaosylceramide (Gg3), gangliotetraosylceramide (Gg4), GM1b, and a new type of disialoganglioside, termed GD1 alpha. In contra...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Murayama K,Levery SB,Schirrmacher V,Hakomori S

    更新日期:1986-03-01 00:00:00

  • Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

    abstract::The insulin-like growth factor-1 receptor (IGF-1R) plays a pivotal role in transformation, growth, and survival of malignant cells, and has emerged as a general and promising target for cancer treatment. However, no fully selective IGF-1R inhibitors have thus far been found. This is explained by the fact that IGF-1R i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-2522

    authors: Girnita A,Girnita L,del Prete F,Bartolazzi A,Larsson O,Axelson M

    更新日期:2004-01-01 00:00:00

  • NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.

    abstract::nm23 was originally identified as an antimetastatic gene, the expression of which was inversely correlated with tumor metastatic potential in rodent model systems. Subsequently, two related human nm23 genes, nm23-H1 and nm23-H2, were identified. The relationship between expression of nm23-H1 and nm23-H2 in hepatocellu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Iizuka N,Oka M,Noma T,Nakazawa A,Hirose K,Suzuki T

    更新日期:1995-02-01 00:00:00

  • Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2.

    abstract::The discovery of oncogenic driver mutations and the subsequent developments in targeted therapies have led to improved outcomes for subsets of lung cancer patients. The identification of additional oncogenic and drug-sensitive alterations may similarly lead to new therapeutic approaches for lung cancer. We identify an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3771

    authors: Tanizaki J,Ercan D,Capelletti M,Dodge M,Xu C,Bahcall M,Tricker EM,Butaney M,Calles A,Sholl LM,Hammerman PS,Oxnard GR,Wong KK,Jänne PA

    更新日期:2015-08-01 00:00:00